McKearn J P, Baum C, Davie J M
J Immunol. 1984 Jan;132(1):332-9.
A large number of monoclonal antibodies, produced by immunizing rats with mouse pre-B cell lines, have been analyzed for their ability to define cell surface antigens expressed by B cells at early stages of differentiation. Whereas many antibodies recognized antigens on pre-B cell lines, only two clones detected cell surface antigens that were distinguished by their restricted distribution among a panel of continuous cell lines and cells from various tissues. Monoclonal antibody clone AA4.1 recognized a cell surface antigen found on all pre-B lymphomas and on one of three B lymphomas tested. This antigen was found on cells at highest frequency in the bone marrow. Adult spleen and fetal liver also have detectable numbers of AA4.1+ cells. Cells that did not express this antigen include plasmacytomas, two of three B lymphomas, T lymphomas, a stem cell line, adult liver, brain, thymus, and lymph node cells. Clone GF1.2 detected an antigen on some pre-B cell lines, one of three B lymphomas tested, and a small fraction of cells from adult bone marrow, spleen, lymph node, and fetal liver. Plasmacytomas, some pre-B lymphomas, two B lymphomas, T lymphomas, adult liver, brain, and thymus cells were negative. In adult bone marrow, AA4.1 bound to all cytoplasmic IgM+ pre-B cells, whereas GF1.2 detected one-half of these cells. Both antibodies recognized approximately 50% of surface IgM+ (sIgM+) bone marrow cells. A small population of bone marrow cells lacking any detectable Ig (surface or cytoplasmic) also reacted with these antibodies. Depletion of AA4.1 or GF1.2 antigen-bearing cells from bone marrow reduced the ability of bone marrow B cells to respond to LPS by 50 to 65%. Experiments with a cloned pre-B lymphoma demonstrate that AA4.1+ pre-B cells become sIgM+ GF1.2+ B cells after activation with LPS. These antibodies recognize cell surface determinants with restricted distribution among the B lymphocyte lineage because they detect antigens displayed by normal and transformed immature B lymphocytes.
通过用小鼠前B细胞系免疫大鼠产生了大量单克隆抗体,已对其界定分化早期B细胞所表达的细胞表面抗原的能力进行了分析。尽管许多抗体识别前B细胞系上的抗原,但只有两个克隆检测到细胞表面抗原,其特点是在一组连续细胞系和来自各种组织的细胞中分布有限。单克隆抗体克隆AA4.1识别在所有前B淋巴瘤以及所检测的三个B淋巴瘤中的一个上发现的细胞表面抗原。该抗原在骨髓细胞中出现的频率最高。成年脾脏和胎儿肝脏中也有可检测数量的AA4.1+细胞。不表达该抗原的细胞包括浆细胞瘤、三个B淋巴瘤中的两个、T淋巴瘤、一个干细胞系、成年肝脏、脑、胸腺和淋巴结细胞。克隆GF1.2在一些前B细胞系、所检测的三个B淋巴瘤中的一个以及成年骨髓、脾脏、淋巴结和胎儿肝脏的一小部分细胞上检测到一种抗原。浆细胞瘤、一些前B淋巴瘤、两个B淋巴瘤、T淋巴瘤、成年肝脏、脑和胸腺细胞均为阴性。在成年骨髓中,AA4.1与所有细胞质IgM+前B细胞结合,而GF1.2检测到其中一半的细胞。两种抗体均识别约50%的表面IgM+(sIgM+)骨髓细胞。一小部分缺乏任何可检测Ig(表面或细胞质)的骨髓细胞也与这些抗体发生反应。从骨髓中去除携带AA4.1或GF1.2抗原的细胞会使骨髓B细胞对LPS的反应能力降低50%至65%。用克隆的前B淋巴瘤进行的实验表明,AA4.1+前B细胞在用LPS激活后会变成sIgM+GF1.2+B细胞。这些抗体识别在B淋巴细胞谱系中分布有限的细胞表面决定簇,因为它们检测到正常和转化的未成熟B淋巴细胞所展示的抗原。